产品说明书

Tween 80

Print
Chemical Structure| 9005-65-6 同义名 : 聚氧乙烯山梨糖醇酐单油酸酯 ;Polysorbate 80
CAS号 : 9005-65-6
货号 : A656812
分子式 : -
纯度 : USP
分子量 : 0
MDL号 : MFCD00082107
存储条件:

粉末 Sealed in dry,Room Temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 Tween 80 is a surfactant which can also reduce bacterial attachment and inhibit biofilm formation.
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT03073525 Advanced Gynecological Cancers... 展开 >> Ovarian Cancer Cervical Cancer Uterine Cancer 收起 << Phase 2 Recruiting April 1, 2019 United States, Alabama ... 展开 >> University of South Alabama Mitchell Cancer Institute Recruiting Mobile, Alabama, United States, 36604 Contact: Rodney Rocconi, MD    251-665-8000    rocconi@health.southalabama.edu    Principal Investigator: Rodney Rocconi, MD          United States, Georgia Augusta University Recruiting Augusta, Georgia, United States, 30912 Contact: Lisa Hatch, RN    706-721-4805    lhatch@augusta.edu    Principal Investigator: Sharad A Ghamande, MD          United States, Michigan Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Nicole Leon, RN    313-916-6781    sleon9@hfhs.org    Principal Investigator: Adnan Munkarah, MD          United States, Montana Billings Clinic Recruiting Billings, Montana, United States, 59101 Contact: Kathy Wilkinson, RN BSN OCN    406-435-7415    kwilkinson@billingsclinic.org    Principal Investigator: Erin Stevens, MD          United States, New Hampshire Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Kathy Phipps, CCRP    603-653-3537    kathy.phipps@hitchcock.org    Principal Investigator: Leslie DeMars, MD          United States, South Carolina GHS Cancer Institute Recruiting Greenville, South Carolina, United States, 29605 Contact: Gina Norris    864-241-6251    gnorris@ghs.org    Principal Investigator: Jeffrey Elder, MD 收起 <<
NCT01635621 Crohn's Disease Phase 2 Withdrawn(Study was withdrawn ... 展开 >>due to delay in timelines. There were no safety concerns regarding the study or the compound in the decision to withdraw the trial.) 收起 << August 2013 -
NCT01266850 Rotavirus Infection Phase 4 Completed - United States, California ... 展开 >> Kaiser Permanente Vaccine Study Center Oakland, California, United States, 94612-3610 Children's Hospital & Research Center Oakland - Primary Care Clinic Oakland, California, United States, 94618-1033 United States, Georgia Emory Children's Center - Pediatric Infectious Diseases Atlanta, Georgia, United States, 30322-1014 United States, Iowa University of Iowa - Vaccine Research & Education Unit Iowa City, Iowa, United States, 52242-2600 United States, Maryland University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States, 21201-1509 United States, Missouri Children's Mercy Hospital and Clinics - Infectious Diseases Kansas City, Missouri, United States, 64108-4619 United States, North Carolina Duke Translational Medicine Institute - Clinical Vaccine Unit Durham, North Carolina, United States, 27704-2120 United States, Pennsylvania Primary Physicians Research Inc. - Pittsburgh Pittsburgh, Pennsylvania, United States, 15241-3100 United States, Tennessee Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center Nashville, Tennessee, United States, 37232-2573 United States, Texas The University of Texas Medical Branch - Sealy Center for Vaccine Development (SCVD) Galveston, Texas, United States, 77555-1121 Baylor College of Medicine - Molecular Virology and Microbiology Houston, Texas, United States, 77030-3411 United States, Washington Group Health Research Institute - Seattle Seattle, Washington, United States, 98101-1466 Seattle Children's Hospital - Infectious Diseases Seattle, Washington, United States, 98105-3901 收起 <<